Company Filing History:
3 out of 832,812 Years Active: 2016-2017
Title: Innovator in Cancer Research: Tai Lin Tseng
Introduction: Tai Lin Tseng is a notable inventor based in Taipei, Taiwan, who has made significant strides in the field of cancer research. With three patents to his name, Tseng is focused on developing methods that target cancer cell growth, which could potentially offer new hope to patients battling various forms of cancer.
Latest Patents: Tseng's latest patents include groundbreaking methods for inhibiting cancer cell growth. One of his innovations involves a method that administers an effective amount of a compound to a subject, which is designed to inhibit the growth of cancer cells. This compound is represented by a specific formula that allows flexibility in its application, with R1 being either a hydrogen atom or an acetyl group. Additionally, he has developed a compound extracted from Antrodia camphorate, accompanied by a method of use aimed at inhibiting cancer cell growth specifically for types of cancer such as lung, colon, prostate, liver, and breast cancers.
Career Highlights: Throughout his career, Tai Lin Tseng has demonstrated a strong commitment to advancing medical science through innovation. His collection of patents not only showcases his inventive spirit but also highlights his dedication to finding solutions for urgent health challenges. By focusing on cancer research, he is paving the way for potential breakthroughs that could impact countless lives.
Collaborations: Tai Lin Tseng collaborates with esteemed colleagues such as Wen-Liang Chang and Chen-Wen Yao, contributing to a dynamic research environment. This collaboration fosters the exchange of ideas and expertise that can accelerate the development of impactful inventions in the field of cancer treatment.
Conclusion: As a dedicated inventor, Tai Lin Tseng is at the forefront of cancer research innovation. His patents reflect a deep understanding of the complexities of cancer biology and a commitment to creating effective treatments. With the ongoing support of his colleagues, Tseng continues to strive for advancements that could greatly benefit patients in need of effective cancer therapies.